QGEN
Qiagen NV

1,416
Mkt Cap
$8.43B
Volume
1.98M
52W High
$57.82
52W Low
$38.13
PE Ratio
19.86
QGEN Fundamentals
Price
$40.60
Prev Close
$41.12
Open
$41.83
50D MA
$49.00
Beta
0.54
Avg. Volume
2.14M
EPS (Annual)
$2.04
P/B
2.21
Rev/Employee
$362,532.35
$10,398.54
Loading...
Loading...
News
all
press releases
Wellington Management Group LLP Lowers Stake in Qiagen N.V. $QGEN
Wellington Management Group LLP reduced its stake in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 10.4% in the third quarter, according to its most recent filing with the SEC. The fund owned...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Qiagen N.V. $QGEN Position Raised by Perbak Capital Partners LLP
Perbak Capital Partners LLP boosted its position in Qiagen N.V. (NYSE:QGEN - Free Report) by 78.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·2d ago
News Placeholder
Qiagen (NYSE:QGEN) Stock Rating Upgraded by Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft raised shares of Qiagen from a "hold" rating to a "buy" rating and set a $54.00 price objective on the stock in a research report on Friday...
MarketBeat·2d ago
News Placeholder
Korea Investment CORP Sells 93,167 Shares of Qiagen N.V. $QGEN
Korea Investment CORP trimmed its holdings in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 37.6% during the 3rd quarter, according to the company in its most recent filing with the Securities...
MarketBeat·3d ago
News Placeholder
Qiagen (NYSE:QGEN) Downgraded by Zacks Research to Strong Sell
Zacks Research downgraded Qiagen from a "hold" rating to a "strong sell" rating in a research report on Monday...
MarketBeat·4d ago
News Placeholder
Jefferies Financial Group Inc. Makes New Investment in Qiagen N.V. $QGEN
Jefferies Financial Group Inc. acquired a new stake in Qiagen N.V. (NYSE:QGEN - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and...
MarketBeat·5d ago
News Placeholder
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the use of all QIAstat-Dx Gastrointestinal (GI) Panels on the...
Business Wire·5d ago
News Placeholder
Natixis Advisors LLC Increases Stock Position in Qiagen N.V. $QGEN
Natixis Advisors LLC grew its holdings in Qiagen N.V. (NYSE:QGEN - Free Report) by 8.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·6d ago
News Placeholder
Qiagen N.V. $QGEN Shares Acquired by Barclays PLC
Barclays PLC increased its stake in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 14.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission...
MarketBeat·6d ago
News Placeholder
Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report?
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·9d ago
<
1
2
...
>

Latest QGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.